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Abstract
The Magu Health and Demographic Surveillance System (Magu HDSS) is part of Kisesa
OpenCohort HIV Study located in a rural area of North-Western Tanzania. Since its estab-
lishment in 1994, information on pregnancies, births, marriages, migrations and deaths
have been monitored and updated between one and three times a year by trained field-
workers. Other research activities implemented in the cohort include: sero surveys which
have been conducted every 2–3 years to collect socioeconomic data, HIV sero status and
health knowledge attitude and behaviour in adults aged 15 years or more living in the
area; verbal autopsy (VA) interviews conducted to establish cause of death in all deaths
encountered in the area; Llnking data collected at health facilities to community-based
data; monitoring voluntary counselling and testing (VCT); and assessing uptake of anti-
retroviral treatment (ART). In addition, within the community, qualitative studies have
been conducted to address issues linked to HIV stigma, the perception of ART access
and adherence.
In 2014, the population was over 35 000 individuals. Magu HDSS has contributed to
Tanzanian estimates of fertility and mortality, and is a member of the INDEPTH network.
Demographic data for Magu HDSS are available via the INDEPTH Network’s Sharing and
Accessing Repository (iSHARE) and applications to access HDSS data for collaborative
analysis are encouraged.
Key words: Demography, fertility, mortality, migration, verbal autopsy, sero survey, INDEPTH network, Magu,
Tanzania
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Why was the HDSS established?
Magu HDSS was established in 1994 by the Tanzania-
Netherlands Support Program on AIDS (TANESA) as one
the vital components of the Kisesa Open Cohort HIV
Study. The Kisesa Open Cohort was set up to monitor the
causes, spread and impact of the HIV/AIDS epidemic in
the general population. The Kisesa Open Cohort is the se-
cond oldest HIV community cohort study in Africa and is
responsible for monitoring population dynamics, HIV, ac-
cess to HIV treatment and the impact of the treatment.
The underlying rationale for the establishment of Magu
HDSS was to create a community-based surveillance sys-
tem to measure child and adult mortality, fertility and mo-
bility in the general population. Magu HDSS data have
been used to measure individual and household impacts of
HIV and antiretroviral therapy (ART). They have also
been used to assess the leading causes of death and changes
in family structure due to the adult mortality. Furthermore
the HDSS has been an important source of data for district
planning at ward and district levels. Since late 1995 several
community interventions have been introduced to promote
safer sexual behaviour. The Magu HDSS is a member of
the INDEPTH network [http://www.indepthnetwork.org]
and the ALPHA network [http://www.lshtm.ac.uk/eph/
psd/alpha].
Where is the HDSS area?
In 1994, Magu HDSS consisted of seven villages wholly
located in Kisesa ward. Kisesa ward is one of the 31 wards
of Magu district (Figure 1). Magu is one of seven districts
of Mwanza Region in North-Western Tanzania. The
Magu HDSS study area lies 20 km east of Mwanza, the re-
gion’s capital city, and is located along the main road to
neighbouring Kenya.
Farming is the main source of income (97%) and com-
monly grown crops are cotton, cassava, paddy, maize and
sweet potatoes, and petty trade of products such as milk,
tomatoes, maize and rice is common. Within the Magu
HDSS area there are four Government-owned health facili-
ties (all providing maternal and child health services) and
three private dispensaries. There are also 15 primary and
three secondary schools in the area.
Who is covered by the HDSS and how often
have they been followed up?
Magu HDSS covers all residents of the Kisesa ward. Data
collection began in 1994 with the baseline census, which
involved listing all individuals living in the HDSS’s geo-
graphical area. The baseline survey led to the creation of
demographic household cards. Households are self-defined
as ‘a group of people living together in the same compound
and who regularly eat together from the same pot’. The
cards contain a list of all individuals living in a particular
household, with each household member having their
own unique HDSS number. HDSS numbers are never re-
assigned to another household member following a mem-
ber’s exit and, if a member leaves and returns to the same
household, they get their old HDSS number back.
At the baseline survey in 1994, the population of
the area was 19 458 inhabitants, subsequently growing
at approximately 2.5–3.0% per year to 35 569 in
2014. Between 1994 and 2014, the Magu HDSS popu-
lation has been updated 28 times through demographic
surveillance follow-up by enumerators who visit all
households in the HDSS area. Initially the updates
were paper based but, since 2012 (HDSS demographic
round 26), the update of the HDSS data have been
done electronically using Personal Digital Assistants
(PDA) (see Figure 2).
A new person (in-migrant) is listed as a household mem-
ber if the household respondent had stayed, or was intend-
ing to stay, in the household for at least 3 months. Those
who left a household in the Magu HDSS and were not ex-
pected to return to that household were considered out-mi-
grants from the household but maintained their line
number, allowing returning household members to be
Key Messages
• Magu HDSS is a platform for HIV epidemiological studies, using a well-established identification procedure for linking
individuals’ health status and family data with social, economic and health facilities data.
• Observed deaths rates among HIV-positive adults were 15 times higher than those among HIV-negative adults, and
nearly half of deaths were associated with HIV/AIDS.
• Mortality among under-fives has declined significantly during the period 1994–2011.
• Due to impact of ARV, a substantial mortality decline has been observed among HIV-positive individuals, at a time
when there is little or no mortality decline in HIV-negative individuals.
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relisted according to their original HDSS numbers. The
main reasons for migration are: marriage, household mi-
gration, employment, returning home and schooling.
The population participation rate during demographic
surveillance follow-up is 98%. High participation rate of
community members in HDSS activities is due to good re-
lationship between the National Institute for Medical
Research (NIMR) team, leaders and community members
of Kisesa ward.
What has been measured and how have the
HDSS databases been constructed?
Different data have been measured at different time peri-
ods over the past two decades using the Magu HDSS as the
framework for the data collection (Figure 3).
Demographic Surveillance System (DSS)
Following the baseline census conducted in 1994, records
are constantly updated. The follow-ups involve visiting
Figure 1.Map showing the Magu Health and Demographic Surveillance area.
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every household in the study area and asking one respond-
ent in each household for information on pregnancy, resi-
dence, death, in-migration, out-migration, birth, marital
status and education (detailed information provided under
Table 1) of all residents in the household. The respondents
are normally heads of household though, on some occa-
sions, the respondent is another responsible adult house-
hold member who is well informed about the household.
Verbal autopsy
Verbal autopsy (VA) is another important piece of research
carried out as part of HDSS work and was initiated in
February 1995. During HDSS listing, all deaths encoun-
tered are listed on a separate form. The listed deaths are
then followed up with a VA interview using the standard
WHO/INDEPTH tool for VA. VA interviews are adminis-
tered by a clinician or clinical officer to the caregiver of the
deceased, to establish the possible cause of death. The VA
interview collects detailed data on circumstances, symp-
toms and signs during the terminal illness of the deceased.
The collected data are assessed by two trained medical
doctors who independently assign the underlying, immedi-
ate and contributory causes of death. If the same diagnoses
are given by the two doctors, this is accepted as the prob-
able cause of death but, in the case of disagreement, a third
Figure 3. Study timelines and frequency for Magu HDSS Kisesa.
Figure 2. Photoes showing tools used for updating HDSS information.
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medical doctor assesses the data and assigns the causes of
death. In addition to VA coding by clinicians, a computer
algorithm InterVA-4 has been used to assign the causes of
death since 2012.1
Sero survey
Regular HIV sero surveys are another major research activ-
ity conducted within the Magu HDSS. All adults aged 15
years or more and living in Magu HDSS have been invited
to participate in the survey. During the sero surveys, spe-
cial temporary clinics are constructed and participants are
invited to come to the clinic serving their villages. At the
clinic, participants go through six stages: registration,
interview, laboratory investigation, treatment, pharmacy
and voluntary counselling and testing (VCT). At the inter-
view stage, participants are interviewed on range of topics
which include: socio-demographic characteristics, birth
history, sexual behaviour, family planning, HIV testing
and use of Antiretrovirals (ARVs) (detailed information
provided in Table 2). Samples for HIV testing are collected
during the laboratory stage. The sample is collected using
dry blood spot (DBS) using filter paper. The DBSs are sub-
mitted to the NIMR Mwanza Centre for HIV testing using
enzyme-linked immunosorbent assay (ELISA). The HIV
testing algorithm includes two ELISAs, i.e. UNIFORMII
(Vironostika HIV1/HIV2-Organon, Boxtel, The
Netherlands) for screening and UNIFORMII (Enzygnost
HIV1/HIV2- Behring, Marburg, Germany) for confirm-
ation. Samples reacting positively on the two tests are
Table 1. Information currently collected on re-enumeration rounds of the HDSS
Main data item Scope of question Specific information
Household ID Each new household Village number, sub-village number,
ten-cell leader number, household number
GPS status Each new household GPS coordinates
Household reported dissolved Each household Yes/no
Is this a new household? Each household Yes/no
Line number of household head Each household
Line number of respondent Each household
Line number All
Names All First, middle and last name
Date of birth All Day, month, year
Sex All Male/female
Status at last round Existing members Resident in the household, alive but moved out of household, dead
Still alive All Alive, dead
Date of death Recently dead Day, month, year
Still resident in this household All Yes/no
Date moved out of household Recently moved out only Day, month, year
Place moved to Recently moved out only Name of place moved to (village code if Kisesa)
Reason for move Recently moved out only
Status of new arrival All new members Birth, returning previous resident, new in-migrant
Mother’s line number New members aged 0–17 Line number, or code showing resident in Kisesa, dead,
live somewhere outside Kisesa, don’t know
Father’s line number New members aged 0–17 Line number, or code showing resident in Kisesa, dead,
live somewhere outside Kisesa, don’t know
Status of in-migrants New/returning members only Resident or visitor
Arrival date New/returning members only Day, month, year
Arrival from New/returning members only Name of place coming from (village code if Kisesa)
Reason for arrival New/returning members only
Slept here last night All Yes/no
Marital status Aged 15þ Never married, married, separated, widowed
Spouse line number(s) Aged 15þ
Pregnant now Female aged 15–49 years Yes/no
Gave birth since last HDSS Female aged 15–49 years Yes/no
Still at school Aged 5–25 years Yes/no
Type of school Those at school only Primary, secondary, tertiary, vocational
Class now attending Those at school only Standard number or form number
Data items shown in bold are already available for existing members. They are displayed on the PDA screen and if correct are not re-entered.
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considered HIV infected. The sero surveys are carried out
at 2–3-year intervals and, since 1994, seven rounds have
been conducted: 1994/95, 1996/97, 1999/2000, 2003/04,
2006/07, 2010 and 2012/13.
Voluntary counselling and testing (VCT) and care
and treatment clinic (CTC) data collection
VCT services were started at Kisesa Health Centre in 2005
through the collaboration of the TAZAMA Project and
Magu District Medical Officer. The VCT clinic offer ser-
vices to all Kisesa ward residents and sometimes those
coming from outside the ward. Those testing HIV-positive
in the VCT are referred to the CTC located at the same
health facility. The CTC services were initiated at the
Kisesa health centre in 2008 through collaboration of the
TAZAMA Project and Magu District Medical Officer. The
services of both VCT and CTC are delivered according to
the guidelines of the Ministry of Health and Social Welfare
(MoHSW). Patient information and data on all visits to the
CTC by enrolled HIV-positive patients are collected using
a national database provided by the National AIDS
Control Programme (NACP). The Access Database has
data which are entered from the CTC ‘patient record card’.
Information collected includes sex, age, marital status, re-
ferral status, pregnancies, CD4 count, signs and symptoms,
Table 2. Information collected at latest questionnaire interview of sero survey round
Subject Specific information
Background information Sex, age, marital status, language use, literacy, education level, religion and ethnicity, residence
(village, ward), duration of stay in that place
Occupation Main economic activity for income generation (farming, business, skilled/unskilled manual, fish-
ing, drivers etc.)
Physical activity Physical activity at work (continuous heavy or vigorous activities like lifting and carrying heavy
loads, digging, hoeing, pounding or chopping); travelling (walking, cycling, vehicle use); social
activities, (sports etc.)
Food Consumption of fruit, vegetables and starches in wet and dry seasons
Alcohol use Frequency, quantity
Tobacco use Frequency, type, quantity
Condoms Knowledge, availability
Family planning Knowledge, uses
Pregnancy and childbirth Ever been pregnant, ever gave birth, currently pregnant, outcome of last pregnancy, place of deliv-
ery, attended ANC during last pregnancy, tested for HIV, syphilis or other blood test during last
pregnancy
Desire for children Want another child yes/no, when, how many more
Marriage Current marital status, first marriage circumstances
Lifetime sexual behaviour Age at first sex, condom use at first sex, number of lifetime sexual partners, number of sexual part-
ner in the past 12 months, reasons for abstinence if no sexual partners in past 12 months
Current sexual partners (loop) Partner details for recent sexual partners: type of partner, cohabitation, age, first and last sex date,
frequency of intercourse, condom use
Non-sexual HIV risk factors Blood transfusion, circumcision, incisions, injections
HIV perception Awareness, knowledge about transmission, knowledge of infection in family and community,
stigma and discrimination among infected
HIV counselling and
testing (HTC)
Number of times use HTC, last time use HTC, receive pre/post counselling in last HTC, disclose
HIV status, recommend HTC to friend, people’s perceptions about those attending HTC
Anti-retroviral therapy
(ART) perceptions
Knowledge, attitude, awareness of use in family and community, local availability
Health services Use and cost of services
Symptoms of specific illnesses Whether experienced recent symptoms of sexual transmitted infections, tuberculosis, diabetes,
schistosomiasis and hypertension
Care and treatment clinic
(CTC) services
Willingness to disclose personal experience of CTC use, ever use, referral
Experience of use of different
CTC clinics (loop)
Clinic name, whether tested, assessed for treatment need, received treatment, opportunistic infec-
tion treatment, adherence counselling
pre-ART monitoring Dates and consistency of attendance
ART use Dates and treatment adherence
Prevention of mother to child
transmission for women aged 15–49
HIV test and counselling at the time of delivery, medicine taken at time of delivery, baby given
medicine to prevent HIV, baby tested for HIV infection, breastfeeding of the last born
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pregnancy status, TB screening, TB treatment, ARV status,
care status, ARV adherence, prophylaxis treatment, nutri-
tional status and next visit date
Qualitative work
Qualitative studies have been used to study perceptions, be-
haviour, attitudes and practice in Magu HDSS, and to find
the reasons why associations found in quantitative studies
are seen. Qualitative studies have focused on exploring fac-
tors influencing attendance at HIV clinics, antiretroviral
therapy scale-up, different types of HIV stigma and volun-
tary counselling and testing uptake, and perceptions and ex-
periences of barriers to accessing the national antiretroviral
programme among self-identified HIV-positive persons.
Qualitative studies have been conducted using in-depth
interviews (IDI), focus group discussion (FGD) and semi-
structured interviews. Interviews and focus group discus-
sions have been conducted among HIV-infected persons,
faith leaders, community leaders and health care providers.
Data management
Since 2010, the HDSS has used electronic data collection
(EDC) where Census and Survey Processing System
(CSpro) version 4.1 is used to produce computer assisted
personal interviewing (CAPI) entry screen for PDA. Then
enumerators record household information directly into
the PDA. Under this system, households in the study area
are organized into batches, with each sub-village represent-
ing a batch. The data manager’s office organizes the
batches and uploads them onto the enumerators’ PDAs
within the CSPro data entry programs. After collection,
each interviewer provides the collected data to the HDSS
supervisor on a flash disk which is then brought to the
HDSS data manager for integration into the Magu HDSS
data management system. A batch editing is applied to
clean errors and the edited data are stored in the Ms
Access and Microsoft Structured Query Language (MS
SQL) server databases on the Magu HDSS server.
Sero survey data have also been collected electronically
since 2012, and are linked to the HDSS data using the indi-
vidual’s current household identifier which is pre-printed
on the invitation slip for giving to eligible participants.
HDSS residents who participate in one or more sero sur-
veys are allocated a unique permanent identification num-
ber which links their sero survey records.
Key findings and publications
The population pyramid of the Magu HDSS signifies high
fertility and mortality in the study area. The pyramid has a
broad base, suggesting that there are a lot births in the
cohort and that the population is growing rapidly
(Figure 4). There is a marked indentation in the age groups
15–39 for both sexes in 2013 compared with 1999—this
may be in part due to HIV-related mortality, but is also a
result of increased out-migration by young adults.
The crude fertility rate fell from 215 [95% confidence
interval (CI) 209–222] births per 1000 person-years (PY) in
the 1994–98 period to 141 (95% CI 138–145) in 2009–13.
In the same period, total fertility rate (TFR) fell from 6.6 to
4.7 births per woman (Figure 5). This is in line with observed
changes in fertility in other sub-Saharan African countries.2
In the period 1994–2013, child mortality by mother’s
HIV status at birth has been high among children born by
HIV-positive mothers compared with those born among
HIV-negative mothers (Figure 6).
In the assessment of deaths in the area, of those that fall
under the top 10 causes of deaths, HIV/AIDS is a major
cause of death for all ages, with a higher proportion of
deaths among females compared to males. Malaria is the
second leading cause of death with more deaths recorded
among males compared with females. Pulmonary tubercu-
losis ranks fourth, with a higher proportion of deaths re-
corded among females than males. Accidents are the fifth
cause of death, with a higher proportion of deaths among
males than females (Figure 7).
Impact of HIV on Mortality
Mortality rates among HIV-infected adults were 15 times
higher than those among HIV-negative adults, and almost
half of the deaths among those in aged 15–44 years were
associated with HIV/AIDS.3 Among infants, there was an
excess risk of infant death among those born to HIV-posi-
tive mothers of 2.9 (95% CI 2.3–3.6) compared with those
born to mothers known to be HIV-negative).4,5
Using data from Kisesa and another longitudinal com-
munity study in Manicaland in Zimbabwe, we investigated
which VA symptoms were most efficient at discriminating
between deaths in HIV-positive and HIV-negative individ-
uals. We concluded that verbal autopsy can consistently
measure AIDS mortality in areas for which HIV testing
and hospital records are unavailable or incomplete.6 In the
mid 1990s there were a third more deaths due to HIV and
AIDS in the Kisesa cohort compared with later years
(2004) when ART was available.7 Due to the impact of
ARV, a substantial mortality decline has been observed
among HIV-positive adults, at a time when there was little
or no mortality decline in HIV-negative individuals.8,9
Factors associated with HIV spread
The level of socioeconomic activities based on the presence
of main roads, frequency of public transport, numbers of
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shops, bars and health facilities and volume and frequency
of trade plays a big role in the spread of HIV in rural areas
of Tanzania.10 The trends and patterns in spread of HIV in
the HDSS are determined by sexual behaviour.11–15
Within families, parental communication about sexual
and reproductive health was limited by lack of appropriate
knowledge and by cultural norms that restricted open discus-
sion about safe sex and interactions with the opposite sex.16
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Figure 4. Population pyramid for Magu HDSS.
Figure 5. Total fertility rate trends between years 1994 and 2013.
Figure 6. Child mortality by mother’s HIV status at birth.
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HIV-positive women were more likely to have used
family planning, particularly hormonal methods.17
Factors associated with uptake of ARV and VCT
Studies on factors associated with uptake of ARV showed
that HIV stigma was the most formidable barrier to access-
ing the service.18,19 Motivation and self-efficacy contribute
to ARV programme retention and are affected by other in-
dividual-level experiences such as perceived health benefits
or disease severity.20 Denial of HIV status was often
associated with using alternative healers, and perceptions
of illness severity influenced HIV clinic attendance.21
Socio-demographic factors, such as marital status, area of
residence and religion, influenced VCT completion among
males and females in different ways, and self-perceived risk
of HIV, prior knowledge of VCT, and sex with a high-risk
partner emerged as important predictors of VCT comple-
tion among both sexes.22 Praying for the sick was a
common practice, and over one-third of respondents said
that prayer could cure HIV; enhancing faith leaders’
understanding of ART’s strengths and pitfalls is an
essential step to engaging them as active partners in ART
scale-up programmes (Intervention programmes).23
VCT services are attracting HIV-infected and high-risk
individuals.24 However, 2 years after the introduction of
antiretroviral therapy, the overall uptake remains low.
Among 3923 participants attending two rounds of linked
serological surveys (2003–04 and 2006–07), VCT comple-
tion in 2006–07 was 17% among the 3702 who were HIV-
negative in both rounds, 19% among the 124 who were
HIV-infected in both rounds and 22% among the 96 who
sero-converted between rounds.25
For publications from 1997 to 2008, visit [http://www.ta
zamaproject.org/] and for publication from 2009 to date, see
Appendix 1 (available as Supplementary data at IJE online).
Future analysis plans
Magu HDSS will continue to monitor progression and dy-
namics of HIV/AIDS in the area, exploring the impact asso-
ciated with uptake of ARV and VCT on mortality and
morbidity in this population. This is especially important
given the greater access to HIV services that is currently
available in the health facilities, and the need for monitoring
the effectiveness of these services. We will perform detailed
analysis on morbidity and mortality trends in adults and chil-
dren and continue using VA to determine causes of deaths in
the population while improving the methods used to analyse
causes of death using improved versions of InterVA. We will
analyse fertility trends in women of child-bearing age and
compare fertility by HIV and treatment status to see if there
is an upturn in fertility rates when most HIV-infected women
receive ART. Finally, we will assess factors associated with
uptake of ARV by linking HDSS data with CTC data ob-
tained from health facilities. Collaboration in these and other
analyses is welcome, as well as collaborative work in de-
veloping new research protocols.
What are the main strengths and
weaknesses?
Strengths
The move to update HDSS information collection from
paper to an electronic personal digital assistance (PDA)
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Figure 7. Distribution of major causes of death (all age groups). ARI & COP, acute respiratory infection and chronic obstructive pulmonary disease;
NCD, non-communicable disease.
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system has reduced the processing time for information up-
date, entry and validation. The PDA system has made it
possible for the full dataset to be available for use and ana-
lysis very soon after the updating and cleaning of the last
HDSS records. Thus the HDSS has increased the value of
the cohort in conducting studies such as the sero surveys
and the linkages to the health facility data.
The study site is currently developing database systems
to improve the tracking of individuals’ movements be-
tween households within the HDSS area. This will improve
migration reconciliation within the HDSS and help to iden-
tify former residents when they move back into the Magu
HDSS, even if they were outside the area for a long time.
They system will also fully link parents and their children.
Weaknesses
The high cost of running demographic surveillance activ-
ities continues to be of great concern, and sometimes activ-
ities are delayed due to the lack of funds. Delays in
implementing HDSS follow-up rounds are a serious short-
coming, as some events like deaths (especially neonatal
deaths), births and short-term mobilities are missed be-
cause of time lapse.
Data sharing and collaborations
Magu HDSS data are held at the NIMR office and are
shared through collaborative research agreement with col-
leagues at the London School of Hygiene and Tropical
Medicinewho have contributed to the study designs. Magu
HDSS has subscribed to the INDEPTH network’s Sharing
and Accessing Repository (iSHARE) data-sharing policy,
and our demographic data are lodged in the iSHARE re-
pository. Applications to access HDSS data for collabora-
tive analysis are encouraged and can be made through the
project coordinator, Mark Urassa, at [urassamark@ya-
hoo.co.uk] or the director of NIMR Mwanza;], John
Changalucha, at [jchangalucha@yahoo.com].
Supplementary Data
Supplementary data are available at IJE online.
Funding
Since the start of the Magu HDSS there have been three major fun-
ders. The first was The Netherlands Government through the
TANESA Project (1994–2002). The second major funder was the
Global Fund for AIDS, TB and Malaria (GFATM) Round 4 during
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